Assessing Response and Prognosis in AL Amyloidosis
Author:
Dispenzieri Angela
Reference62 articles.
1. Kyle RA, Greipp PR. Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo. Blood 1978;52:818–27.
2. Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR. Amyloidosis. Best Pract Res Clin Haematol. 2005;18:709–27.
3. Benson MD. Treatment of AL amyloidosis with melphalan, prednisone, and colchicine. Arthritis rheum. 1986;29:683–7.
4. Gertz MA, Kyle RA, Greipp PR. Response rates and survival in primary systemic amyloidosis. Blood 1991;77:257–62.
5. Kyle RA, Gertz MA, Greipp PR, et al. Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood 1999;93:1062–6.